---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-26-000214"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2026-08-20T20:06:02+00:00"
generated_at: "2026-08-20T20:07:12.965485+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Clover Health publishes supplemental Q&A on Q2 2026 results and outlook

## Summary
- Clover Health published a supplemental shareholder Q&A on August 20, 2026, addressing Q2 2026 results and 2026 outlook.
- The Q&A document, furnished as Exhibit 99.1, includes only an introductory letter from CEO Andrew Toy; no Q&A content is provided in the excerpt.
- No specific financial figures, guidance changes, or operational updates are disclosed in the available text.

## SEC filing metadata
- accession: 0001801170-26-000214
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2026-08-20T20:06:02+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000214/0001801170-26-000214-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117026000214/clov-20260820.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-26-000214
- JSON: https://secwatch.observer/filing/0001801170-26-000214.json
- Plain text: https://secwatch.observer/filing/0001801170-26-000214.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.